Protherics PLC Total Voting Rights and Share Capital London, UK; Brentwood, TN; 28 December 2006 - In conformity with the Transparency Directive's transitional provision 6, Protherics PLC ("Protherics"), the international biopharmaceutical company focused on critical care and cancer, is required to notify the market of the following: Protherics' issued share capital consists of 261,489,793 ordinary shares with a nominal value of 2 pence each, with voting rights. Protherics does not hold any ordinary shares in Treasury. Therefore, the total number of voting rights in Protherics is 261,489,793. The above figure of 261,489,793 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Protherics under the Financial Service Authority's Disclosure and Transparency Rules. Ends For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, David Yates +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange END
Protherics PLC announces Total Voting Rights
| Source: Protherics PLC
Cheshire, UK -- (MARKET WIRE) -- December 28, 2006 --